Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters.
The estrogenic activities of eight phthalate esters (i.e., di-2-ethylhexyl, di-n-butyl (DBP), butylbenzyl (BBP), di-hexyl (DHP), diiso-heptyl, di-n-octyl, diiso-nonyl, diiso-decyl) were investigated in vitro using estrogen receptor (ER) competitive ligand-binding and mammalian- and yeast-based gene expression assays. In vivo, their effects on uterine wet weight and vaginal cell cornification using ovariectomized Sprague-Dawley rats were assessed. DBP, BBP, and DHP weakly competed with 17 beta-estradiol (E2) for binding to the ER in competitive ligand-binding assays. In gene expression assays using MCF-7 cells transiently transfected with the Gal4-human estrogen receptor construct, Gal4-HEGO, and the Gal4-regulated luciferase reporter gene, 17m5-G-Luc, 10 microM DBP, BBP, or DHP exhibited 36, 42, and 20% activity, respectively, when compared to the 100% response observed with 10 nM E2. Only BBP was found to induce luciferase activity (32%) in HeLa cells stably transfected with Gal4-HEGO and 17m5-G-Luc constructs and to impart minimal ER-mediated viability to the E2-dependent recombinant yeast strain, PL3, on selective medium. No significant responses were observed with the other phthalate esters in any of the in vitro assays. In vivo, none of the eight phthalate esters reproducibly induced significant increases in uterine wet weight in immature ovariectomized Sprague-Dawley rats treated with oral doses of 20, 200, or 2000 mg/kg of phthalate ester. In addition, treatment with phthalate esters at the same doses did not affect the degree of vaginal epithelial cell cornification in mature ovariectomized rats. These results indicate that only selected phthalate esters (i.e., DBP, BBP, and DHP) exhibit weak ER-mediated activity in some in vitro assays at high concentrations but none of the eight phthalate esters elicited in vivo estrogenic responses based upon results obtained from uterotrophic and vaginal cornification assays.
Zacharewski
T R
TR
Department of Pharmacology and Toxicology, University of Western Ontario, London, Canada. tzachare@pilot.msu.edu
Meek
M D
MD
Clemons
J H
JH
Wu
Z F
ZF
Fielden
M R
MR
Matthews
J B
JB
D000818:Animals; D001667:Binding, Competitive; D002478:Cells, Cultured; D004967:Estrogens / Q000235:genetics / Q000494:pharmacology*; D005260:Female; D005658:Fungi / Q000187:drug effects / Q000235:genetics; D006801:Humans; D066298:In Vitro Techniques; D008024:Ligands; D015394:Molecular Structure; D009929:Organ Size / Q000187:drug effects*; D010052:Ovariectomy; D010795:Phthalic Acids / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011960:Receptors, Estrogen / Q000502:physiology*; D011994:Recombinant Proteins; D014162:Transfection; D014599:Uterus / Q000166:cytology / Q000187:drug effects*
D004967:Estrogens; D008024:Ligands; D010795:Phthalic Acids; D011960:Receptors, Estrogen; D011994:Recombinant Proteins